Literature DB >> 26709759

Role of the tumor microenvironment in pancreatic adenocarcinoma.

Xian-Jun Sun1, Ting-Hui Jiang1, Xiao-Ping Zhang, Ai-Wu Mao2.   

Abstract

Pancreatic cancer is a devastating disease with proclivity for early metastasis, which accounts for its poor prognosis. The clinical problem of pancreatic cancer is its resistance to conventional therapies, such as chemotherapy or radiation. Based upon these challenges, the focus of research on pancreatic cancer has shifted gradually towards the tumor microenvironment. The cancer microenvironment consists of various components, including fibroblasts, endothelial cells, immune cells, and endocrine cells, that interact with each other, and with the cancer cells in a complex fashion. Evidence is accumulating that the cancer microenvironment plays an active role in disease progression, and efforts are being made to target this interplay between cancer cells and host cells, to improve the prognosis of the disease. In the present review, we describe the cellular microenvironment of pancreatic ductal adenocarcinoma (PDA), the major type of pancreatic cancer. Our hope is that a better understanding of the cellular microenvironment of PDA will eventually lead to better treatments for this disease.

Entities:  

Mesh:

Year:  2016        PMID: 26709759     DOI: 10.2741/4374

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  4 in total

1.  The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).

Authors:  Tao Lianyuan; Xiu Dianrong; Yuan Chunhui; Ma Zhaolai; Jiang Bin
Journal:  Cancer Biol Ther       Date:  2018-02-22       Impact factor: 4.742

Review 2.  Polymer nanoparticle-assisted chemotherapy of pancreatic cancer.

Authors:  Tianqi Su; Bo Yang; Tianren Gao; Tongjun Liu; Jiannan Li
Journal:  Ther Adv Med Oncol       Date:  2020-05-08       Impact factor: 8.168

3.  CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.

Authors:  Hui-Feng Gao; Chien-Shan Cheng; Jian Tang; Ye Li; Hao Chen; Zhi-Qiang Meng; Zhen Chen; Lian-Yu Chen
Journal:  Aging (Albany NY)       Date:  2020-01-08       Impact factor: 5.682

Review 4.  Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).

Authors:  Ranzhiqiang Yang; Yinghui Song; Kashif Shakoor; Weimin Yi; Chuang Peng; Sulai Liu
Journal:  Mol Med Rep       Date:  2022-03-18       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.